MNPR News
Archived Headlines
- Monopar Therapeutics cuts share offering in half again ahead of $10 million IPO 12/13/19
- US IPO Weekly Recap: Small Chinese and healthcare deals price down in an 8-IPO week 11/08/19
- Oncology biotech Monopar Therapeutics postpones $20 million IPO 11/07/19
- Monopar Therapeutics cuts share offering in half ahead of $20 million IPO 11/04/19
- US IPO Weekly Recap: Oncology biotech Aprea Therapeutics finishes on top in 4-IPO week 10/04/19
See more
US IPO Weekly Recap: Micro-cap biotech Monopar Therapeutics jumps 238% in 2-IPO week
Just two micro-cap companies entered the public markets in the last week before the holidays kick off, led by oncology biotech Monopar Therapeutics (MNPR) which popped 231% on its first day, the biggest since 2005. One company submitted an...read more
Micro-cap Monopar Therapeutics soars 231% in best IPO pop since 2005
Monopar Therapeutics, which is developing therapies for chemotherapy-induced mucositis and cancers, popped 231% on Friday, the best first-day pop for an IPO since Baidu in 2005. The company raised $9 million by offering 1.1 million shares at $8, the low end...read more
Micro-cap oncology biotech Monopar Therapeutics prices IPO at $8 low end
Monopar Therapeutics, which is developing therapies for chemotherapy-induced mucositis and cancers, raised $9 million by offering 1.1 million shares at $8, the low end of the range of $8 to $10, to command an $89 million market value. Insiders indicated on $6...read more
US IPO Week Ahead: Holiday hibernation is on the horizon with just 2 small IPOs this week
Just two micro-cap companies are expected to IPO as we enter the last week before the holidays. Micro-cap onshore E&P Indonesia Energy (INDO) is expected to raise $15 million at a $75 million market cap. The company operates one...read more